Pharmaceutical

miRagen Therapeutics (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today reported fourth quarter and full year 2017 financial results and provided a corporate update. As quoted in the press release: “2017 was a remarkable year for miRagen, underscored by the clinical success and advancement of our two lead …

miRagen Therapeutics (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today reported fourth quarter and full year 2017 financial results and provided a corporate update.

As quoted in the press release:

“2017 was a remarkable year for miRagen, underscored by the clinical success and advancement of our two lead programs, cobomarsen (MRG-106) and MRG-201, and we believe we are well-positioned to make advances in the development of our product candidates in 2018,” said miRagen President and Chief Executive Officer William S. Marshall, Ph.D. “The cobomarsen Phase 1 results have been encouraging, and we plan to initiate a Phase 2 clinical trial to evaluate cobomarsen in cutaneous T-cell lymphoma (CTCL) this year. We have designed this trial to allow the possibility of accelerated approval in the United States, subject to the outcome of the trial. In 2018, we expect to initiate four clinical trials, including the Phase 2 SOLAR trial evaluating cobomarsen in CTCL, a Phase 2 trial for MRG-201 in cutaneous fibrosis and two Phase 1 trials in collaboration with Servier for MRG-110 to support development in ischemic diseases. Additionally, in 2018 we expect to report interim data from our Phase 1 trial evaluating cobomarsen in multiple hematological malignancies beyond CTCL.”

Click here to read the full press release.

Featured

MARKETS

Markets
TSX20099.81+400.76
TSXV696.65+29.40
DOW32196.66+466.36
S&P 5004023.89+93.81
NASD11805.00+434.04
ASX6941.00-123.70

COMMODITIES

Commodities
Gold1811.05-9.43
Silver21.09+0.29
Copper4.17+0.07
Palladium1942.50+9.50
Platinum942.50-4.50
Oil110.04+3.91
Heating Oil3.76+0.02
Natural Gas7.63-0.11

DOWNLOAD FREE REPORTS

×